HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters
Muhammad Masroor, Zeba Haque
Abstract
BACKGROUND AND AIMS: ) as a biomarker to predict non-alcoholic fatty liver disease (NAFLD) and its severity, compared with body mass index (BMI), waist to hip ratio (WHR) and waist circumference (WC). METHODS: was determined by turbidimetric inhibition immunoassay. RESULTS: possessed a positive predictive value of 76% for the study population [0.76, confidence interval (CI): 0.715-0.809], 70.6% for males (0.706, CI: 0.629-0.783) and 80% for females (0.80, CI: 0.741-0.858). CONCLUSIONS: may be presented as a potential biomarker for NAFLD in examination with other anthropometric measures in the adult population.
Topics & Concepts
MedicineInternal medicineFatty liverWaistBody mass indexOdds ratioGastroenterologyOverweightWaist–hip ratioConfidence intervalSteatosisAnthropometryPopulationBiomarkerDiseaseEnvironmental healthBiochemistryChemistryLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationDiet, Metabolism, and Disease